Clinical Trial Update: Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial results for Androxal (enclomiphene citrate) evaluating blood glucose control in men with Type 2 Diabetes Mellitus and secondary hypogonadism have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism Secondary
• Type 2 Diabetes Mellitus

Drugs mentioned

• Androxal (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Type 2 Diabetes Mellitus, Secondary Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2014-07-24